Nipro Vialex – 26th January 2025
PCI – 7th June 2024
Temax_Krautz

Current Edition

Nasal & Pulmonary Drug Development
Novo Nordisk 20 March 2024, 11:21
Carterra – 24th March 2025

IDT Provides Optimized Conditions for HDR in CRISPR Editing

As an advocate for the genomics age, Integrated DNA Technologies (IDT), has published a new application note on optimization of CRISPR-Cas9 for homology-directed repair (HDR) applications. Available as part of the IDT collection of CRISPR application notes and protocols, this article supports researchers using CRISPR in their genome editing studies to maximize HDR rate in knock-in and other short-insertion experiments.
 
Described as ‘true genome editing’, HDR is the most precise and error-free repair process available for breaks introduced in CRISPR experiments. However, due to the generally low baseline rate of HDR, optimizing reagents and experimental conditions becomes critical to maximize HDR-mediated insertions. This application note offers practical advice from IDT genomics experts, based on thorough optimization studies. This includes experiment planning, sequence design, preparation of reagents, delivery of CRISPR components, and verification of inserts.
 
This new resource adds to IDT’s extensive and continually updated library of genomics topics and underlines IDT’s commitment to developing new tools and techniques for genome editing and supporting scientists with up-to-date educational content for success in their work.
 
For more information, please visit www.idtdna.com, or follow IDT on twitter @idtdna for real-time updates and insights.
 

Scott Pharma – 25.03.2025
SMI – 24/03/2025
Chemspec Europe – 27.02.2025
PHARMAP: Mon 14 October 2024, 10.36
FujiFilm Skyscraper: 26th November 2024
Woolcool 26 March 2024, 16:16
Biopharma group 6 March 2024, 09:40
EyeC 18 March 2024, 13:10
L.B. Bohle – 08.04.2025